Amgen Analyst Likes Diversified Business, Remains Patient Until MariTide Obesity Data
Key takeaways
- Amgen’s solid Q3 earnings and higher 2026 boost confidence in its diversified portfolio, lifting the stock toward its 52‑week peak.
guidance
What a company says it expects for future sales or profits — a forecast from the company, not a guarantee.
- Adjusted earnings $6.45 per share
- Sales $10.365 billion
- Guided $22.90‑$23.70
EPS
Earnings per share — profit for one share of the company, in dollars.
What happened
Amgen Inc. (NASDAQ: AMGN) reported third‑quarter earnings that beat expectations, with adjusted earnings of $6.45 per share versus the consensus of $5.79 and sales of $10.365 billion versus $10.071 billion. The company lifted its fiscal 2026 What a company says it expects for future sales or profits — a forecast from the company, not a guarantee. Earnings per share — profit for one share of the company, in dollars.guidance
EPS
Why it matters
The stronger-than‑expected results and higher What a company says it expects for future sales or profits — a forecast from the company, not a guarantee.guidance
Short-term and longer-term
Short-term. Over the next few days, traders should watch for any short‑term volatility as the stock approaches its 52‑week high.
Longer-term. For investors looking ahead, the upgraded What a company says it expects for future sales or profits — a forecast from the company, not a guarantee.guidance
Words on this card
- Adjusted earnings
- Net income per share after removing one‑time items
- Guidance
- Company’s forecast for future financial performance
- 52‑week high
- The highest price the stock has traded at in the past year
- EPS Learn
- Earnings per share — profit for one share of the company, in dollars.
- Earnings Learn
- A company’s results report — usually profit and sales for a quarter, plus any update on what comes next.